Feb. 28, 2019—Vanderbilt’s newest endowed chair holders were celebrated for their path-breaking scholarship and research by family members, donors, colleagues and friends during a Feb. 25 ceremony.
Feb. 27, 2019—Sandra Rosenthal will step down as director of the Vanderbilt Institute for Nanoscale Science and Engineering on June 30 following 12 years of service.
Jan. 30, 2019—What is more daring—camping in a remote part of Antarctica for a month doing field research, or directing and performing in a musical revue about the environment? For Earth and Environmental Sciences major Andrew Grant, pushing boundaries to positively impact the Earth, and the people who call it home, are equally thrilling.
Jan. 24, 2019—Teams of makers from Vanderbilt and beyond raced the clock to create innovative solutions to the problems facing those living with disabilities as part of Vanderbilt’s Tikkun Olam Makers (TOM) makeathon.
Jan. 9, 2019—Peabody College's Douglas Fuchs and Lynn Fuchs served as guest editors of the January issue of "Exceptional Children."
Jan. 9, 2019—Vanderbilt University has increased its presence in "Education Week’s" annual listing of the most influential public scholars in education.
Jan. 8, 2019—Vanderbilt's Center for Technology Transfer and Commercialization, the Vanderbilt Institute of Chemical Biology and Deerfield will bring together experts in discovery and development of antibody therapeutics Jan. 23 to discuss and review state-of-the-art developments in the field.
Jan. 4, 2019—Craig Lindsley, co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been named a fellow of the National Academy of Inventors.
Jan. 4, 2019—Vanderbilt (VU and VUMC) may nominate one applicant for the RWJF Health and Climate Solutions Grant.
Vanderbilt, Boehringer Ingelheim announce partnership to develop therapies for psychiatric disorders
Jan. 3, 2019—Boehringer Ingelheim and Vanderbilt Center for Neuroscience Drug Discovery today announced two new global agreements to investigate, develop and commercialize novel small molecules targeting two distinct G-protein coupled receptors known to engage in the modulation of certain brain circuitries, which are altered in neuropsychiatric conditions such as schizophrenia.
Jan. 2, 2019—Vanderbilt's Center for Technology Transfer and Commercialization, the Vanderbilt Institute of Chemical Biology and Deerfield will bring together experts in discovery and development of antibody therapeutics Jan. 23 to discuss and review state-of-the-art developments in the field.
Dec. 14, 2018—Ansari will challenge the common assumption that symbols for numbers acquire their meaning by being mapped onto the pre-existing, phylogenetically ancient system for the approximate representation of non-symbolic numbers.